002422 Stock Overview
Researches, develops, manufactures, distributes, and sells pharmaceutical products in China.
| Snowflake Score | |
|---|---|
| Valuation | 6/6 |
| Future Growth | 1/6 |
| Past Performance | 4/6 |
| Financial Health | 6/6 |
| Dividends | 4/6 |
Rewards
Risk Analysis
Sichuan Kelun Pharmaceutical Co., Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CN¥30.81 |
| 52 Week High | CN¥35.49 |
| 52 Week Low | CN¥21.60 |
| Beta | 0.067 |
| 11 Month Change | 0.23% |
| 3 Month Change | -4.91% |
| 1 Year Change | 7.50% |
| 33 Year Change | 67.99% |
| 5 Year Change | -1.88% |
| Change since IPO | 106.22% |
Recent News & Updates
Is Sichuan Kelun Pharmaceutical (SZSE:002422) Using Too Much Debt?
Jul 12
Sichuan Kelun Pharmaceutical Co., Ltd.'s (SZSE:002422) Prospects Need A Boost To Lift Shares
Jun 11An Intrinsic Calculation For Sichuan Kelun Pharmaceutical Co., Ltd. (SZSE:002422) Suggests It's 45% Undervalued
May 21Sichuan Kelun Pharmaceutical's (SZSE:002422) Earnings Are Weaker Than They Seem
May 02Recent updates
Is Sichuan Kelun Pharmaceutical (SZSE:002422) Using Too Much Debt?
Jul 12Sichuan Kelun Pharmaceutical Co., Ltd.'s (SZSE:002422) Prospects Need A Boost To Lift Shares
Jun 11An Intrinsic Calculation For Sichuan Kelun Pharmaceutical Co., Ltd. (SZSE:002422) Suggests It's 45% Undervalued
May 21Sichuan Kelun Pharmaceutical's (SZSE:002422) Earnings Are Weaker Than They Seem
May 02If EPS Growth Is Important To You, Sichuan Kelun Pharmaceutical (SZSE:002422) Presents An Opportunity
Mar 19Sichuan Kelun Pharmaceutical Co., Ltd. (SZSE:002422) Surges 25% Yet Its Low P/E Is No Reason For Excitement
Mar 04These 4 Measures Indicate That Sichuan Kelun Pharmaceutical (SZSE:002422) Is Using Debt Safely
Feb 27Shareholder Returns
| 002422 | CN Pharmaceuticals | CN Market | |
|---|---|---|---|
| 7D | -3.8% | -4.0% | -2.8% |
| 1Y | 7.5% | -18.8% | -21.0% |
Return vs Industry: 002422 exceeded the CN Pharmaceuticals industry which returned -18.8% over the past year.
Return vs Market: 002422 exceeded the CN Market which returned -21% over the past year.
Price Volatility
| 002422 volatility | |
|---|---|
| 002422 Average Weekly Movement | 3.9% |
| Pharmaceuticals Industry Average Movement | 5.1% |
| Market Average Movement | 5.8% |
| 10% most volatile stocks in CN Market | 9.0% |
| 10% least volatile stocks in CN Market | 3.9% |
Stable Share Price: 002422 has not had significant price volatility in the past 3 months.
Volatility Over Time: 002422's weekly volatility (4%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1996 | 19,798 | Sichuan Liu | www.kelun.com |
Sichuan Kelun Pharmaceutical Co., Ltd. researches, develops, manufactures, distributes, and sells pharmaceutical products in China. It offers infusion products; oral medication and other dosage form; plastic ampoule and powder liquid dual chamber infusion bag; medical devices, such as infusion set, injection syringes, detained needles, nebulizer, and blood sampling; and over-the-counter products. The company was founded in 1996 and is based in Chengdu, the People's Republic of China.
Sichuan Kelun Pharmaceutical Co., Ltd. Fundamentals Summary
| 002422 fundamental statistics | |
|---|---|
| Market cap | CN¥49.01b |
| Earnings (TTM) | CN¥2.67b |
| Revenue (TTM) | CN¥22.04b |
18.4x
P/E Ratio2.2x
P/S RatioIs 002422 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 002422 income statement (TTM) | |
|---|---|
| Revenue | CN¥22.04b |
| Cost of Revenue | CN¥10.49b |
| Gross Profit | CN¥11.55b |
| Other Expenses | CN¥8.88b |
| Earnings | CN¥2.67b |
Last Reported Earnings
Mar 31, 2024
Next Earnings Date
Aug 29, 2024
| Earnings per share (EPS) | 1.68 |
| Gross Margin | 52.41% |
| Net Profit Margin | 12.11% |
| Debt/Equity Ratio | 19.7% |
How did 002422 perform over the long term?
See historical performance and comparison